Baker Brothers Life Sciences LP's Net Worth

$1.29 Billion

Estimate Recalculated Mar 1, 2024 09:32PM EST

Who is Baker Brothers Life Sciences LP?

Baker Brothers Life Sciences LP has an estimated net worth of $1.29 Billion. This is based on reported shares across multiple companies, which include Seagen Inc., BeiGene, Ltd., INCYTE CORP, Prelude Therapeutics Inc, XOMA Corp, Kiniksa Pharmaceuticals, Ltd., Zymeworks Inc., IGM Biosciences, Inc., Kodiak Sciences Inc., ACADIA PHARMACEUTICALS INC, IDERA PHARMACEUTICALS, INC., DBV Technologies S.A., TScan Therapeutics, Inc., Neoleukin Therapeutics, Inc., Aeglea BioTherapeutics, Inc., Talis Biomedical Corp, ALEXION PHARMACEUTICALS, INC., MADRIGAL PHARMACEUTICALS, INC., SYNAGEVA BIOPHARMA CORP, GENOMIC HEALTH INC, Mirati Therapeutics, Inc., and BIOCRYST PHARMACEUTICALS INC.

SEC CIK

Baker Brothers Life Sciences LP's CIK is 0001363364

Past Insider Trading and Trends

2016 was Baker Brothers Life Sciences LP's most active year for acquiring shares with 359 total transactions. Baker Brothers Life Sciences LP's most active month to acquire stocks was the month of April. 2019 was Baker Brothers Life Sciences LP's most active year for disposing of shares, totalling 369 transactions. Baker Brothers Life Sciences LP's most active month to dispose stocks was the month of October. 2013 saw Baker Brothers Life Sciences LP paying a total of $53,799,449,047.59 for 550,002,849 shares, this is the most they've acquired in one year. In 2013 Baker Brothers Life Sciences LP cashed out on 117,349,500 shares for a total of $49,999,570,365.60, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BeiGene, Ltd. (BGNE) Snapshot price: $148.38

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-9.43%
-1.10M
$180.50
-$198,550,000.00
10.57M
Nov 14
Form 4
+38.25%
51.69K
186.83K
Jun 15
Form 4
+97.65%
66.77K
135.14K
Jun 22
Form 4
+83.93%
31.2K
68.37K
Jun 16
Form 4
-1.03%
-121.15K
$220.50
-$26,714,457.00
11.67M
Jan 4
Form 4
-11.53%
-1.54M
$220.50
-$333,295,893.00
11.81M
Oct 13 - Dec 4
Form 4
+276.32%
14.58M
$14.23
$207,544,548.74
19.86M
Jul 15
Form 4
0
0
Jun 17
Form 4
-35.69%
-651.49K
1.17M
Jun 5 - Jun 6
Form 4
+15,636.87%
5.81M
$108.00
$627,922,800.00
5.85M
Aug 2
Form 4
+0.05%
37.16K
79.73M
Jun 6
Form 4
+51.44%
1.98M
$101.00
$199,999,998.00
5.83M
Jan 18
Form 4
-71.13%
-35.00K
14.2K
Oct 13
Form 4
+4.79%
176.06K
$71.00
$12,499,976.00
3.85M
Aug 11
Form 4
0
0
Apr 19
Form 4
+92.04%
1.76M
$32.00
$56,335,840.00
3.67M
Nov 18
Form 4
+64.92%
82.25M
$10.01
$47,654,320.28
208.94M
Feb 8
Form 3
0
0
No matching records found

Prelude Therapeutics Inc (PRLD) Snapshot price: $2.92

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Dec 13
Form 4
0
0
Jun 16
Form 4
0
0
May 22
Form 4
0
0
Jun 17
Form 4
0
0
Jun 18
Form 4
+0.10%
10.38K
$12.85
$133,331.60
10.13M
Jan 27
Form 4
0
0
Jan 11
Form 4
+49.15%
9.91M
$19.00
$29,999,993.00
30.08M
Mar 27 - Sep 29
Form 3
0
0
No matching records found

Kiniksa Pharmaceuticals, Ltd. (KNSA) Snapshot price: $18.49

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.62%
17.49K
2.84M
Jun 6
Form 4
+0.71%
20K
2.82M
Jun 29
Form 4
0
0
Jun 29
Form 4
0
0
Jul 24
Form 4
0
0
Jun 30
Form 4
0
0
May 18
Form 4
-57.03%
-170.74K
128.66K
Jun 6
Form 4
0
0
May 29
Form 4
0
0
Feb 4
Form 4
3M
$18.00
$54,000,000.00
3M
Feb 9 - May 29
Form 3
0
0
No matching records found

Zymeworks Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 8
Form 4
0
0
Mar 16
Form 3
0
0
No matching records found

IGM Biosciences, Inc. (IGMS) Snapshot price: $11.97

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.03%
1.11K
3.71M
Dec 29
Form 4
+2.67%
532.69K
$6.26
$3,431,463.82
20.45M
Dec 13 - Dec 15
Form 4
+0.03%
1.11K
3.17M
Sep 29
Form 4
+0.03%
1.11K
3.17M
Jun 30
Form 4
0
0
Jun 26
Form 4
0
0
Apr 4
Form 4
+0.03%
1.11K
3.17M
Mar 31
Form 4
0
0
Apr 1
Form 4
0
0
Mar 12
Form 4
0
0
Feb 19
Form 4
+0.36%
22.42K
$28.14
$641,853.82
6.32M
Jan 27
Form 4
+0.01%
446
3.15M
Dec 31
Form 4
0
0
Dec 11
Form 4
+0.01%
446
3.15M
Oct 1
Form 4
+0.01%
446
3.14M
Jul 1
Form 4
+0.01%
446
3.14M
Apr 1
Form 4
0
0
Feb 5
Form 4
3.14M
$16.00
$50,304,000.00
3.14M
Sep 20
Form 4
0
0
Sep 17
Form 3
0
0
No matching records found